Startups
Supported by an advanced AI-driven analysis engine, the Galenband system monitors a wearers heart rhythm for extended durations, and performs in-depth analysis of gathered data to identify potential indications of silent atrial fibrillation at an early stage.
Overview
Location
Ireland, Connacht, Galway City
Employees
1-10
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 18, 2024 | Three Irish start-ups selected for semi-finals of EIT Health Catapult | Three innovative Irish healthcare start-ups have advanced to the next round of the prestigious EIT Health Catapult 2024-25 pitching competition. EIT Health Ireland-UK, a co-location centre of EIT Health and part of the EU's European In... |
| Jul 4, 2019 | A Fitbit For Heart Arrhythmia | Enterprise Ireland is giving a grant of €500,000 to biomedical engineer Oisín McGrath to develop a wrist-worn device whose aim is to reduce rates of stroke and heart failure. McGrath, who is based at NUI Galway, wants to commercialise his G... |
Reviews 0
FAQ about Galenband
What has the press written about Galenband?
Parsers VC has collected 3 articles mentioning Galenband, among them “Three Irish start-ups selected for semi-finals of EIT Health Catapult” (Nov 18, 2024) and “A Fitbit For Heart Arrhythmia” (Jul 4, 2019).
Is Galenband still active?
Yes, Galenband is active; its latest activity on Parsers VC dates from Sep 28, 2026.